A Trial Investigating the Pain-relieving Properties of Lu AG06474 in Healthy Adult Participants
Status:
Recruiting
Trial end date:
2024-05-17
Target enrollment:
Participant gender:
Summary
The main goal of this trial is to learn about the effect of Lu AG06474 on a battery of Evoked
Pain Tests when a single dose is given to healthy adult participants. The effects of Lu
AG06474 will be compared with 2 approved pain-relieving medications (ibuprofen and
pregabalin) and with a placebo (a treatment that looks like the trial treatment but does not
have any medicine in it). Each participant will receive 1 dose of each of these treatments
during the trial (Lu AG06474, ibuprofen, pregabalin, and placebo), with 1 week between
treatments. All treatments will be taken orally (by mouth), either as a liquid or a capsule.